News and Announcements
Octagon Strategy Featured at Several Global Conferences & Major Media Publications Including Bloomberg, The Washington Post, CNBC & More
- Published August 04, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Octagon Strategy Limited is the largest digital asset OTC trading desk in the APAC region. They facilitate the buying and selling of digital assets including bitcoin, ether, and ripple. The team comprises of seasoned professionals in banking technology and financial trading which grants them a unique blend of market insight, network of relationships, trading acumen and sophisticated trading strategies. By sustaining deep pools of liquidity, Octagon is able to offer competitive pricing and unlimited global, same-day settlement options.
With excellent market understanding, the Octagon team is often invited to speak at global conferences, and has been featured in major media publications such as Bloomberg, The Washington Post, CNBC, CoinDesk and more.
ABOUT OCTAGON STRATEGY LIMITED
Octagon Strategy Limited is a privately-owned company specializing in commodity and digital asset trading across international markets.
We combine over 25 years of experience in the finance industry with our market insights, network of relationships, trading acumen, and sophisticated trading strategies.
We are focused on generating absolute returns by trading and investing our capital strategically. We seek to capitalize on opportunities by leveraging our experience with state of the art proprietary technology and risk management capabilities.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
